Recombinant Human Tumor necrosis factor receptor superfamily member 10B protein (TNFRSF10B) Active

Catalog No : IGX-RP2107-1MG
1145.03€
0.00€

Shipping cost plus VAT not included , delivery in 7-14 business days

Product name Recombinant Human Tumor necrosis factor receptor superfamily member 10B protein (TNFRSF10B) Active
Catalog No IGX-RP2107-1MG
Supplier’s Catalog No IGX-RP2107-1MG
Supplier ImuGeX
Source antigen Recombinant, expressed in E.Coli, 52-183 Amino Acids
Reactivity Human
Cross reactivity Human
Applications Functional studies, Bioassays or User optimised
Molecular weight 7.8 KDa
Storage Store at -20℃/-80℃.
Other names Death receptor 5, TRAIL receptor 2, TRAIL-R2, CD antigen CD262,
Grade Highly Purified
Purity >96% determined by SDS-PAGE and HPLC, Endotoxin Level: <1.0 EU/µg as determined by LAL method.
Form Lyophilized from a 0.2µm filtered PBS, pH 7.4
Reactivity life 12 months, when stored accoring to instructions.
Note For reserch purpose only, not for In Vivo use or as therapeutics.
Purity >96% determined by SDS-PAGE and HPLC, Endotoxin Level: <1.0 EU/µg as determined by LAL method.
Description Receptor for the cytotoxic ligand TNFSF10/TRAIL Sequence: ESALITQQDL APQQRAAPQQ KRSSPSEGLC PPGHHISEDG RDCISCKYGQ DYSTHWNDLL FCLRCTRCDS GEVELSPCTT TRNTVCQCEE GTFREEDSPE MCRKCRTGCP RGMVKVGDCT PWSDIECVHK ES140. Biological Activity: Biologically Fully Active when compared to standard. rHusTRAIL-R2 reduced the production of LPS- induced TNF by its ability to neutralize endogenous TRAIL in fresh human PBMC. In this assay, endogenous TRAIL is induced during a 24 hour exposure to LPS (10 ng/mL) but in the presence of rHusTRAIL-R2, TRAIL-induced TNF is suppressed.